Proteintech Genomics Launches the MultiPro Human Discovery Panel: A New Frontier in Single-Cell Multiomics
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics Against NanoString's CosMx SMI Products
Leerink Partners Maintains 10x Genomics(TXG.US) With Buy Rating
TD Cowen Maintains 10x Genomics(TXG.US) With Hold Rating, Cuts Target Price to $18
Strategic Pricing and Market Expansion Drive 10x Genomics Buy Rating
TD Cowen Reaffirms Their Hold Rating on 10x Genomics (TXG)